{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T21:11:36Z","timestamp":1774991496102,"version":"3.50.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No.82200220"],"award-info":[{"award-number":["No.82200220"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82500274"],"award-info":[{"award-number":["No. 82500274"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82470196"],"award-info":[{"award-number":["No. 82470196"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100018525","name":"Key Research and Development Program of Sichuan Province","doi-asserted-by":"publisher","award":["2024YFFK0321"],"award-info":[{"award-number":["2024YFFK0321"]}],"id":[{"id":"10.13039\/501100018525","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018525","name":"Key Research and Development Program of Sichuan Province","doi-asserted-by":"publisher","award":["No. 2023YFS0031"],"award-info":[{"award-number":["No. 2023YFS0031"]}],"id":[{"id":"10.13039\/501100018525","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Post-doctor Research Fund of West China Hospital, Sichuan University","award":["2024HXBH090"],"award-info":[{"award-number":["2024HXBH090"]}]},{"DOI":"10.13039\/501100018542","name":"Sichuan Natural Science Foundation","doi-asserted-by":"crossref","award":["2024NSFSC1697"],"award-info":[{"award-number":["2024NSFSC1697"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"crossref"}]},{"name":"1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University","award":["No. ZYJC21007"],"award-info":[{"award-number":["No. ZYJC21007"]}]},{"name":"National Key Research and Development Program of China","award":["No.2022YFC2502600"],"award-info":[{"award-number":["No.2022YFC2502600"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10495-026-02292-4","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T18:05:58Z","timestamp":1773252358000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of KPNA3 in multiple myeloma: implications for targeting nuclear import"],"prefix":"10.1007","volume":"31","author":[{"given":"Hongmei","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyue","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingcao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haonan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangfang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinai","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuanyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjiao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"2292_CR1","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jama.2022.0003","volume":"327","author":"AJ Cowan","year":"2022","unstructured":"Cowan AJ, Green DJ, Kwok M et al (2022) Diagnosis and management of multiple myeloma: a review. JAMA 327:464\u2013477","journal-title":"JAMA"},{"key":"2292_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-024-00188-w","volume":"5","author":"Q Lu","year":"2024","unstructured":"Lu Q, Yang D, Li H, Niu T, Tong A (2024) Multiple myeloma: signaling pathways and targeted therapy. Mol Biomed 5:25","journal-title":"Mol Biomed"},{"key":"2292_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1001\/jama.2021.25306","volume":"327","author":"J Silberstein","year":"2022","unstructured":"Silberstein J, Tuchman S, Grant SJ (2022) What is multiple myeloma? JAMA 327:497\u2013497","journal-title":"JAMA"},{"key":"2292_CR4","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1038\/s41375-020-0921-y","volume":"34","author":"CJ Neuse","year":"2020","unstructured":"Neuse CJ, Lomas OC, Schliemann C et al (2020) Genome instability in multiple myeloma. Leukemia 34:2887\u20132897","journal-title":"Leukemia"},{"key":"2292_CR5","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1038\/s41375-020-0958-y","volume":"34","author":"B Nachmias","year":"2020","unstructured":"Nachmias B, Schimmer AD (2020) Targeting nuclear import and export in hematological malignancies. Leukemia 34:2875\u20132886","journal-title":"Leukemia"},{"key":"2292_CR6","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.cellsig.2015.01.013","volume":"27","author":"W Yan","year":"2015","unstructured":"Yan W, Li R, He J, Du J, Hou J (2015) Importin \u03b21 mediates nuclear factor-\u03baB signal transduction into the nuclei of myeloma cells and affects their proliferation and apoptosis. Cell Signal 27:851\u2013859","journal-title":"Cell Signal"},{"key":"2292_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ceb.2018.01.006","volume":"52","author":"T \u00c7a\u011fatay","year":"2018","unstructured":"\u00c7a\u011fatay T, Chook YM (2018) Karyopherins in cancer. Curr Opin Cell Biol 52:30\u201342","journal-title":"Curr Opin Cell Biol"},{"key":"2292_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00698-1","volume":"19","author":"B Khalil","year":"2024","unstructured":"Khalil B, Linsenmeier M, Smith CL, Shorter J, Rossoll W (2024) Nuclear-import receptors as gatekeepers of pathological phase transitions in ALS\/FTD. Mol Neurodegener 19:8","journal-title":"Mol Neurodegener"},{"key":"2292_CR9","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.tcb.2004.07.016","volume":"14","author":"DS Goldfarb","year":"2004","unstructured":"Goldfarb DS, Corbett AH, Mason DA, Harreman MT, Adam SA (2004) Importin alpha: a multipurpose nuclear-transport receptor. Trends Cell Biol 14:505\u2013514","journal-title":"Trends Cell Biol"},{"key":"2292_CR10","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1182\/blood-2014-02-557819","volume":"124","author":"YX Zhu","year":"2014","unstructured":"Zhu YX, Braggio E, Shi CX et al (2014) Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma. Blood 124:536\u2013545","journal-title":"Blood"},{"key":"2292_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0873-2","volume":"17","author":"T Liu","year":"2018","unstructured":"Liu T, Han Z, Li H, Zhu Y, Sun Z, Zhu A (2018) LncRNA DLEU1 contributes to colorectal cancer progression via activation of KPNA3. Mol Cancer 17:118","journal-title":"Mol Cancer"},{"key":"2292_CR12","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2023.2235770","volume":"24","author":"XW Wang","year":"2023","unstructured":"Wang XW, Jiang YH, Ye W, Shao CF, Xie JJ, Li X (2023) SIRT1 promotes the progression and chemoresistance of colorectal cancer through the p53\/miR-101\/KPNA3 axis. Cancer Biol Ther 24:2235770","journal-title":"Cancer Biol Ther"},{"key":"2292_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.5483\/BMBRep.2022-0180","volume":"56","author":"J Choi","year":"2023","unstructured":"Choi J, Choi JH, Lee HW et al (2023) KPNA3 promotes epithelial-mesenchymal transition by regulating TGF-\u03b2 and AKT signaling pathways in MDA-MB-231, a triple-negative breast cancer cell line. BMB Rep 56:120\u2013125","journal-title":"BMB Rep"},{"key":"2292_CR14","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1182\/blood-2014-03-557298","volume":"124","author":"Z Liu","year":"2014","unstructured":"Liu Z, Xu J, He J et al (2014) A critical role of autocrine sonic hedgehog signaling in human CD138+ myeloma cell survival and drug resistance. Blood 124:2061\u20132071","journal-title":"Blood"},{"key":"2292_CR15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0959-437X(03)00002-9","volume":"13","author":"C Wetmore","year":"2003","unstructured":"Wetmore C (2003) Sonic hedgehog in normal and neoplastic proliferation: insight gained from human tumors and animal models. Curr Opin Genet Dev 13:34\u201342","journal-title":"Curr Opin Genet Dev"},{"key":"2292_CR16","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1101\/gad.1693608","volume":"22","author":"M Varjosalo","year":"2008","unstructured":"Varjosalo M, Taipale J (2008) Hedgehog: functions and mechanisms. Genes Dev 22:2454\u20132472","journal-title":"Genes Dev"},{"key":"2292_CR17","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.1182\/blood-2011-07-368142","volume":"120","author":"S Blotta","year":"2012","unstructured":"Blotta S, Jakubikova J, Calimeri T et al (2012) Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma. Blood 120:5002\u20135013","journal-title":"Blood"},{"key":"2292_CR18","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1101\/gad.938601","volume":"15","author":"PW Ingham","year":"2001","unstructured":"Ingham PW, McMahon AP (2001) Hedgehog signaling in animal development: paradigms and principles. Genes Dev 15:3059\u20133087","journal-title":"Genes Dev"},{"key":"2292_CR19","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nature03100","volume":"432","author":"PA Beachy","year":"2004","unstructured":"Beachy PA, Karhadkar SS, Berman DM (2004) Tissue repair and stem cell renewal in carcinogenesis. Nature 432:324\u2013331","journal-title":"Nature"},{"key":"2292_CR20","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1182\/blood.2021014761","volume":"142","author":"PW Krenn","year":"2023","unstructured":"Krenn PW, Aberger F (2023) Targeting cancer hallmark vulnerabilities in hematologic malignancies by interfering with Hedgehog\/GLI signaling. Blood 142:1945\u20131959","journal-title":"Blood"},{"key":"2292_CR21","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.1182\/bloodadvances.2021004695","volume":"5","author":"H Luo","year":"2021","unstructured":"Luo H, Zhang D, Wang F et al (2021) ALCAM-EGFR interaction regulates myelomagenesis. Blood Adv 5:5269\u20135282","journal-title":"Blood Adv"},{"key":"2292_CR22","doi-asserted-by":"publisher","first-page":"4048","DOI":"10.1073\/pnas.0611682104","volume":"104","author":"CD Peacock","year":"2007","unstructured":"Peacock CD, Wang Q, Gesell GS et al (2007) Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc Natl Acad Sci U S A 104:4048\u20134053","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2292_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djw131","author":"Y Zheng","year":"2016","unstructured":"Zheng Y, Wang Q, Li T et al (2016) Role of myeloma-derived MIF in myeloma cell adhesion to bone marrow and chemotherapy response. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djw131","journal-title":"J Natl Cancer Inst"},{"key":"2292_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000189","author":"F Choueiry","year":"2020","unstructured":"Choueiry F, Torok M, Shakya R et al (2020) CD200 promotes immunosuppression in the pancreatic tumor microenvironment. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2019-000189","journal-title":"J Immunother Cancer"},{"key":"2292_CR25","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/cac2.12130","volume":"41","author":"S Li","year":"2021","unstructured":"Li S, Zhang J, Qian S et al (2021) S100A8 promotes epithelial-mesenchymal transition and metastasis under TGF-\u03b2\/USF2 axis in colorectal cancer. Cancer Commun 41:154\u2013170","journal-title":"Cancer Commun"},{"key":"2292_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1010271","volume":"18","author":"VC Sanchez","year":"2022","unstructured":"Sanchez VC, Yang HH, Craig-Lucas A et al (2022) Host CLIC4 expression in the tumor microenvironment is essential for breast cancer metastatic competence. PLoS Genet 18:e1010271","journal-title":"PLoS Genet"},{"key":"2292_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13112829","author":"X Kong","year":"2021","unstructured":"Kong X, Wang D, Sun W et al (2021) Small proline-rich protein 2A and 2D are regulated by the RBM38-p73 axis and associated with p73-dependent suppression of chronic inflammation. Cancers. https:\/\/doi.org\/10.3390\/cancers13112829","journal-title":"Cancers"},{"key":"2292_CR28","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1158\/0008-5472.CAN-24-0291","volume":"84","author":"X Wang","year":"2024","unstructured":"Wang X, Qu Y, Xu Q et al (2024) NQO1 triggers neutrophil recruitment and NET formation to drive lung metastasis of invasive breast cancer. Cancer Res 84:3538\u20133555","journal-title":"Cancer Res"},{"key":"2292_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02098-1","volume":"21","author":"X Li","year":"2021","unstructured":"Li X, Chen W, Yang C et al (2021) IGHG1 upregulation promoted gastric cancer malignancy via AKT\/GSK-3\u03b2\/\u03b2-catenin pathway. Cancer Cell Int 21:397","journal-title":"Cancer Cell Int"},{"key":"2292_CR30","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/s12967-025-06200-3","volume":"23","author":"X Deng","year":"2025","unstructured":"Deng X, Ma C, Chen X et al (2025) Acetylation suppresses breast cancer progression by sustaining CLYBL stability. J Transl Med 23:415","journal-title":"J Transl Med"},{"key":"2292_CR31","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.apsb.2021.02.008","volume":"11","author":"H Zhang","year":"2021","unstructured":"Zhang H, Fu L (2021) The role of ALDH2 in tumorigenesis and tumor progression: targeting ALDH2 as a potential cancer treatment. Acta Pharm Sin B 11:1400\u20131411","journal-title":"Acta Pharm Sin B"},{"key":"2292_CR32","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1038\/s41375-025-02687-3","volume":"39","author":"J Atkins","year":"2025","unstructured":"Atkins J, Kukuyan AM, Toma M et al (2025) ADH5\/ALDH2 dehydrogenases and DNA polymerase theta protect normal and malignant hematopoietic cells from formaldehyde challenge: therapeutic implications. Leukemia 39:2152\u20132162","journal-title":"Leukemia"},{"key":"2292_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01579-9","volume":"21","author":"W Wang","year":"2022","unstructured":"Wang W, Wang J, Liu S et al (2022) An EHMT2\/NFYA-ALDH2 signaling axis modulates the RAF pathway to regulate paclitaxel resistance in lung cancer. Mol Cancer 21:106","journal-title":"Mol Cancer"},{"key":"2292_CR34","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1124\/pr.111.005538","volume":"64","author":"V Koppaka","year":"2012","unstructured":"Koppaka V, Thompson DC, Chen Y et al (2012) Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application. Pharmacol Rev 64:520\u2013539","journal-title":"Pharmacol Rev"},{"key":"2292_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00017.2013","volume":"94","author":"CH Chen","year":"2014","unstructured":"Chen CH, Ferreira JC, Gross ER, Mochly-Rosen D (2014) Targeting aldehyde dehydrogenase 2: new therapeutic opportunities. Physiol Rev 94:1\u201334","journal-title":"Physiol Rev"},{"key":"2292_CR36","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1158\/1535-7163.MCT-18-1167","volume":"18","author":"G Kallifatidis","year":"2019","unstructured":"Kallifatidis G, Smith DK, Morera DS et al (2019) \u03b2-arrestins regulate stem cell-like phenotype and response to chemotherapy in bladder cancer. Mol Cancer Ther 18:801\u2013811","journal-title":"Mol Cancer Ther"},{"key":"2292_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216218","volume":"565","author":"H Luo","year":"2023","unstructured":"Luo H, Feng Y, Wang F et al (2023) Combinations of ivermectin with proteasome inhibitors induce synergistic lethality in multiple myeloma. Cancer Lett 565:216218","journal-title":"Cancer Lett"},{"key":"2292_CR38","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.pt.2017.02.004","volume":"33","author":"R Laing","year":"2017","unstructured":"Laing R, Gillan V, Devaney E (2017) Ivermectin - old drug, new tricks? Trends Parasitol 33:463\u2013472","journal-title":"Trends Parasitol"},{"key":"2292_CR39","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2147\/DDDT.S237393","volume":"14","author":"J Liu","year":"2020","unstructured":"Liu J, Zhang K, Cheng L, Zhu H, Xu T (2020) Progress in understanding the molecular mechanisms underlying the antitumour effects of ivermectin. Drug Des Devel Ther 14:285\u2013296","journal-title":"Drug Des Devel Ther"},{"key":"2292_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-025-00687-w","volume":"30","author":"C Yin","year":"2025","unstructured":"Yin C, Liufu C, Ye S et al (2025) Tumor-derived exosomal KPNA2 activates fibroblasts and interacts with KIFC1 to promote bladder cancer progression, a process inhibited by miR-26b-5p. Cell Mol Biol Lett 30:20","journal-title":"Cell Mol Biol Lett"},{"key":"2292_CR41","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/path.4390","volume":"234","author":"K Ikenberg","year":"2014","unstructured":"Ikenberg K, Valtcheva N, Brandt S et al (2014) KPNA2 is overexpressed in human and mouse endometrial cancers and promotes cellular proliferation. J Pathol 234:239\u2013252","journal-title":"J Pathol"},{"key":"2292_CR42","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1038\/bjc.2015.165","volume":"112","author":"AT Alshareeda","year":"2015","unstructured":"Alshareeda AT, Negm OH, Green AR et al (2015) KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer. Br J Cancer 112:1929\u20131937","journal-title":"Br J Cancer"},{"key":"2292_CR43","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.bbadis.2016.09.015","volume":"1863","author":"EM Vuorinen","year":"2017","unstructured":"Vuorinen EM, Rajala NK, Rauhala HE, Nurminen AT, Hyt\u00f6nen VP, Kallioniemi A (2017) Search for KPNA7 cargo proteins in human cells reveals MVP and ZNF414 as novel regulators of cancer cell growth. Biochim Biophys Acta Mol Basis Dis 1863:211\u2013219","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2292_CR44","doi-asserted-by":"publisher","first-page":"4116","DOI":"10.1182\/blood.V99.11.4116","volume":"99","author":"D Mertens","year":"2002","unstructured":"Mertens D, Wolf S, Schroeter P et al (2002) Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia. Blood 99:4116\u20134121","journal-title":"Blood"},{"key":"2292_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16081024","author":"S Guo","year":"2024","unstructured":"Guo S, Zheng S, Liu M, Wang G (2024) Novel anti-cancer stem cell compounds: a comprehensive review. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics16081024","journal-title":"Pharmaceutics"},{"key":"2292_CR46","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1002\/stem.1160","volume":"30","author":"R Santini","year":"2012","unstructured":"Santini R, Vinci MC, Pandolfi S et al (2012) Hedgehog-GLI signaling drives self-renewal and tumorigenicity of human melanoma-initiating cells. Stem Cells 30:1808\u20131818","journal-title":"Stem Cells"},{"key":"2292_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-025-02736-x","author":"S Zocchi","year":"2025","unstructured":"Zocchi S, Trichet P, Guernalec P et al (2025) The long non-coding RNA CRNDE stabilises SIRT1 protein and influences Hedgehog signalling in multiple myeloma. Leukemia. https:\/\/doi.org\/10.1038\/s41375-025-02736-x","journal-title":"Leukemia"},{"key":"2292_CR48","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0167-4781(98)00115-8","volume":"1399","author":"MJ Stewart","year":"1998","unstructured":"Stewart MJ, Dipple KM, Estonius M, Nakshatri H, Everett LM, Crabb DW (1998) Binding and activation of the human aldehyde dehydrogenase 2 promoter by hepatocyte nuclear factor 4. Biochim Biophys Acta 1399:181\u2013186","journal-title":"Biochim Biophys Acta"},{"key":"2292_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15337","volume":"8","author":"YH Gao","year":"2017","unstructured":"Gao YH, Wu ZX, Xie LQ et al (2017) VHL deficiency augments anthracycline sensitivity of clear cell renal cell carcinomas by down-regulating ALDH2. Nat Commun 8:15337","journal-title":"Nat Commun"},{"key":"2292_CR50","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1006\/abbi.2000.1915","volume":"380","author":"J Pinaire","year":"2000","unstructured":"Pinaire J, Hasanadka R, Fang M et al (2000) The retinoid X receptor response element in the human aldehyde dehydrogenase 2 promoter is antagonized by the chicken ovalbumin upstream promoter family of orphan receptors. Arch Biochem Biophys 380:192\u2013200","journal-title":"Arch Biochem Biophys"},{"key":"2292_CR51","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.2148-24.2025","author":"Y Qu","year":"2025","unstructured":"Qu Y, Wu Y, Xu X et al (2025) MiR-153 prevents NRF2 nuclear translocation to drive hypoperfusion-related cognitive deficits by targeting KPNA5. J Neurosci. https:\/\/doi.org\/10.1523\/jneurosci.2148-24.2025","journal-title":"J Neurosci"},{"key":"2292_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00903-4","volume":"13","author":"NG Azizian","year":"2020","unstructured":"Azizian NG, Li Y (2020) XPO1-dependent nuclear export as a target for cancer therapy. J Hematol Oncol 13:61","journal-title":"J Hematol Oncol"},{"key":"2292_CR53","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1039\/D1CS00269D","volume":"53","author":"R Goswami","year":"2024","unstructured":"Goswami R, Gupta A, Bednova O et al (2024) Nuclear localization signal-tagged systems: relevant nuclear import principles in the context of current therapeutic design. Chem Soc Rev 53:204\u2013226","journal-title":"Chem Soc Rev"},{"key":"2292_CR54","doi-asserted-by":"publisher","first-page":"23139","DOI":"10.1074\/jbc.M909256199","volume":"275","author":"IS Kim","year":"2000","unstructured":"Kim IS, Kim DH, Han SM et al (2000) Truncated form of importin alpha identified in breast cancer cell inhibits nuclear import of p53. J Biol Chem 275:23139\u201323145","journal-title":"J Biol Chem"},{"key":"2292_CR55","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/84683","volume":"7","author":"P Vigneri","year":"2001","unstructured":"Vigneri P, Wang JY (2001) Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase. Nat Med 7:228\u2013234","journal-title":"Nat Med"},{"key":"2292_CR56","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.semcancer.2014.04.005","volume":"27","author":"WT Senapedis","year":"2014","unstructured":"Senapedis WT, Baloglu E, Landesman Y (2014) Clinical translation of nuclear export inhibitors in cancer. Semin Cancer Biol 27:74\u201386","journal-title":"Semin Cancer Biol"},{"key":"2292_CR57","doi-asserted-by":"publisher","first-page":"10455","DOI":"10.2147\/OTT.S210048","volume":"12","author":"T Wang","year":"2019","unstructured":"Wang T, Huang Z, Huang N et al (2019) Inhibition of KPNB1 inhibits proliferation and promotes apoptosis of chronic myeloid leukemia cells through regulation of E2F1. Onco Targets Ther 12:10455\u201310467","journal-title":"Onco Targets Ther"},{"key":"2292_CR58","doi-asserted-by":"publisher","first-page":"4700","DOI":"10.1038\/s41388-019-0745-2","volume":"38","author":"J Yang","year":"2019","unstructured":"Yang J, Guo Y, Lu C et al (2019) Inhibition of karyopherin beta 1 suppresses prostate cancer growth. Oncogene 38:4700\u20134714","journal-title":"Oncogene"},{"key":"2292_CR59","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1158\/1535-7163.MCT-15-0052","volume":"15","author":"PJ van der Watt","year":"2016","unstructured":"van der Watt PJ, Chi A, Stelma T et al (2016) Targeting the nuclear import receptor Kpn\u03b21 as an anticancer therapeutic. Mol Cancer Ther 15:560\u2013573","journal-title":"Mol Cancer Ther"},{"key":"2292_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/cells7110221","author":"FK Kosyna","year":"2018","unstructured":"Kosyna FK, Depping R (2018) Controlling the gatekeeper: therapeutic targeting of nuclear transport. Cells. https:\/\/doi.org\/10.3390\/cells7110221","journal-title":"Cells"},{"key":"2292_CR61","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.6308762","volume":"221","author":"WC Campbell","year":"1983","unstructured":"Campbell WC, Fisher MH, Stapley EO, Albers-Sch\u00f6nberg G, Jacob TA (1983) Ivermectin: a potent new antiparasitic agent. Science 221:823\u2013828","journal-title":"Science"},{"key":"2292_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/cancers8070066","author":"K Ahmed","year":"2016","unstructured":"Ahmed K, Shaw HV, Koval A, Katanaev VL (2016) A second WNT for old drugs: drug repositioning against WNT-dependent cancers. Cancers. https:\/\/doi.org\/10.3390\/cancers8070066","journal-title":"Cancers"},{"key":"2292_CR63","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1042\/BJ20120150","volume":"443","author":"KM Wagstaff","year":"2012","unstructured":"Wagstaff KM, Sivakumaran H, Heaton SM, Harrich D, Jans DA (2012) Ivermectin is a specific inhibitor of importin \u03b1\/\u03b2-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus. Biochem J 443:851\u2013856","journal-title":"Biochem J"},{"key":"2292_CR64","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1182\/blood-2010-01-262675","volume":"116","author":"S Sharmeen","year":"2010","unstructured":"Sharmeen S, Skrtic M, Sukhai MA et al (2010) The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells. Blood 116:3593\u20133603","journal-title":"Blood"},{"key":"2292_CR65","first-page":"3397","volume":"17","author":"G Dominguez-Gomez","year":"2018","unstructured":"Dominguez-Gomez G, Chavez-Blanco A, Medina-Franco JL et al (2018) Ivermectin as an inhibitor of cancer stem-like cells. Mol Med Rep 17:3397\u20133403","journal-title":"Mol Med Rep"},{"key":"2292_CR66","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.jsps.2022.06.024","volume":"30","author":"HA Alghamdi","year":"2022","unstructured":"Alghamdi HA, Al-Zharani M, Aljarba NH et al (2022) Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats. Saudi Pharm J 30:1273\u20131282","journal-title":"Saudi Pharm J"},{"key":"2292_CR67","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s13046-019-1251-7","volume":"38","author":"L Jiang","year":"2019","unstructured":"Jiang L, Wang P, Sun YJ, Wu YJ (2019) Ivermectin reverses the drug resistance in cancer cells through EGFR\/ERK\/Akt\/NF-\u03baB pathway. J Exp Clin Cancer Res 38:265","journal-title":"J Exp Clin Cancer Res"},{"key":"2292_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/sigtrans.2016.10","volume":"1","author":"Q Sun","year":"2016","unstructured":"Sun Q, Chen X, Zhou Q, Burstein E, Yang S, Jia D (2016) Inhibiting cancer cell hallmark features through nuclear export inhibition. Signal Transduct Target Ther 1:16010","journal-title":"Signal Transduct Target Ther"},{"key":"2292_CR69","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.3324\/haematol.11199","volume":"92","author":"D Cilloni","year":"2007","unstructured":"Cilloni D, Martinelli G, Messa F, Baccarani M, Saglio G (2007) Nuclear factor kB as a target for new drug development in myeloid malignancies. Haematologica 92:1224\u20131229","journal-title":"Haematologica"},{"key":"2292_CR70","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s41375-019-0404-1","volume":"33","author":"H van Andel","year":"2019","unstructured":"van Andel H, Kocemba KA, Spaargaren M, Pals ST (2019) Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options. Leukemia 33:1063\u20131075","journal-title":"Leukemia"},{"key":"2292_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105207","volume":"163","author":"M Tang","year":"2021","unstructured":"Tang M, Hu X, Wang Y et al (2021) Ivermectin, a potential anticancer drug derived from an antiparasitic drug. Pharmacol Res 163:105207","journal-title":"Pharmacol Res"},{"key":"2292_CR72","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1177\/009127002237994","volume":"42","author":"CA Guzzo","year":"2002","unstructured":"Guzzo CA, Furtek CI, Porras AG et al (2002) Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects. J Clin Pharmacol 42:1122\u20131133","journal-title":"J Clin Pharmacol"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02292-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-026-02292-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02292-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:01:59Z","timestamp":1774987319000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-026-02292-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2292"],"URL":"https:\/\/doi.org\/10.1007\/s10495-026-02292-4","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Bone marrow aspirates from MM patients were obtained from the tissue bank of the Department of Hematology, West China Hospital, Sichuan University. Informed consent was obtained, and the study protocol was approved by the Ethical Committee of West China Hospital of Sichuan University and conformed to the Declaration of Helsinki. All animal experiments were conducted in accordance with the guidelines and ethical standards approved by Sichuan University, West China Institutional Animal Care and Use Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"98"}}